Stable Istotope Labelled Ranibizumab Biosimilar – Anti-VEGF mAb – Research Grade

Reference: PX-TA1008-SIL-1MG
Product nameStable Istotope Labelled Ranibizumab Biosimilar - Anti-VEGF mAb - Research Grade
SourceDrugBank DB01270
SpeciesHuman
Expression systemMammalian cells
Molecular weight48kDa
Purity>95%
BufferPBS pH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
Aliases /SynonymsRanibizumab
ReferencePX-TA1008-SIL
Related ProductsPX-P1167
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeFabG1
ClonalityMonoclonal Antibody
SourceDrugBank DB01270
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year
FormulaC2158H3282N562O681S12

General information about Ranibizumab

Ranibizumab is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab. It is an anti-angiogenic that has been approved to treat the “wet” type of age-related macular degeneration (AMD, also ARMD), diabetic retinopathy, and macular edema due to branch retinal vein occlusion or central retinal vein occlusion. This product is for research use only.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Istotope Labelled Ranibizumab Biosimilar – Anti-VEGF mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.